DAVITA INC. Co Selected Measure Amt
DAVITA INC. (DVA) reported Co Selected Measure Amt of $10.78 per share for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-22.
Financial Statements › Notes
ecd:CoSelectedMeasureAmt · last filed 2026-04-22
| Period end | Co Selected Measure Amt 12 month |
|---|---|
| 2025-12-31 | $10.78 DEF 14A · filed 2026-04-22 |
| 2024-12-31 | $10.69 DEF 14A · filed 2026-04-22 |
| 2023-12-31 | $8.19 DEF 14A · filed 2026-04-22 |
| 2022-12-31 | $7.13 DEF 14A · filed 2026-04-22 |
| 2021-12-31 | $9.24 DEF 14A · filed 2026-04-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |